CEO Nils Brünner interviewed by BioStock about the positive development

CEO Nils Brünner has been interviewed about the milestones and the positive development in Scandion Oncology.

10JUN2020 BioStock_SCANDION_20200610__PDF

https://www.biostock.se/2020/06/scandion-oncologys-kursutveckling-i-topp/

Co-funded by the Horizon 2020 programme of the European Union
Co-funded by the COSME programme of the European Union